Covaxin for kids: Bharat Biotech completes phase 2/3 trials of vaccine, to submit data to DCGI next week21 Sep, 2021, 03.04 PM ISTCovaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech17 Jun, 2022, 12.15 PM ISTCoronavirus vaccine: ICMR partners with BBIL to develop indigenous COVID-19 vaccine09 May, 2020, 08.37 PM ISTIndia banks turn cautious on MSME lending as stress signals emerge: Report
NEET-UG re-exam: Students say Physics paper tougher than earlier attempt
Harmanpreet Kaur becomes first ever cricketer to play 200 T20Is
UK PM Keir Starmer to decide Monday on stay or quit after Burnham win
Trump says Starmer will quit as UK PM after 'failing badly' on immigration, energy
Melinda Gates urges tech tycoons to donate half their wealth
JD(U) reposes trust in Nitish, calls Nishant its future
Modi leads Yoga Day celebrations in Kolkata, Murmu performs 'asanas' at Jabalpur
Kerala: One more Shigella death, seven fresh cases reported
SBI's improving performance warrants better valuation, chairman Setty says: Report
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service